The emerging literature data from recently published clinical trials on severe COVID-19 patients revealed that high circulating levels of IL-6, IL-1β, IL-8 and TNF-α were associated with poor prognosis and higher mortality rates [32,33,34]. The gene discussed is TNF; the disease is COVID-19.